Lung cancer is characterised by genderspecific differences in carcinogenesis, prevalence
and types of mutations as well as response to targeted therapies. The impact of a patient's
gender on the tumor's DNA methylation pattern and on the efficiency of latest epigenetic
therapies is still unknown and thus the research topic of this project.
The Project is funded by FFG Talente - 4th Call FEMtech Research Projects.